18735506. FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS simplified abstract (NORTHWESTERN UNIVERSITY)
Contents
FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS
Organization Name
Inventor(s)
Udo Rudloff of Bethesda MD (US)
Serguei Kozlov of Bethesda MD (US)
Juan Jose Marugan of Gaithersburg MD (US)
Samarjit Patnaik of Gaithersburg MD (US)
John C. Braisted of Boyds MD (US)
Noel T. Southall of Potomac MD (US)
Marc Ferrer of Potomac MD (US)
Christopher Dextras of Frederick MD (US)
John Haslam of Lawrence KS (US)
Michael Baltezor of Shawnee KS (US)
FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS - A simplified explanation of the abstract
This abstract first appeared for US patent application 18735506 titled 'FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS
The abstract of the patent application describes pharmaceutical formulations containing a compound of formula (I).
- The patent application focuses on pharmaceutical formulations incorporating a specific compound.
- The compound of formula (I) is a key ingredient in the formulations.
- The formulations are designed for pharmaceutical use.
- The innovation lies in the specific combination and formulation of the compound.
- The patent application likely pertains to the development of new drugs or treatments.
Potential Applications:
- The pharmaceutical formulations could be used in the development of new medications.
- The compound of formula (I) may have therapeutic applications in various medical conditions.
Problems Solved:
- The patent application addresses the need for effective pharmaceutical formulations.
- It aims to provide new treatment options for medical conditions.
Benefits:
- The formulations could lead to the development of innovative medications.
- Patients may benefit from improved treatment options.
Commercial Applications:
- The pharmaceutical formulations could have commercial applications in the pharmaceutical industry.
- The innovation may lead to the creation of new drugs with market potential.
Questions about the Technology: 1. What specific medical conditions could the pharmaceutical formulations potentially treat?
- The formulations may have applications in a range of medical conditions, depending on the properties of the compound of formula (I).
2. How does the compound of formula (I) differ from existing pharmaceutical ingredients?
- The patent application likely highlights the unique properties or benefits of the compound compared to existing ingredients.
Original Abstract Submitted
Disclosed are pharmaceutical formulations comprising a compound of formula (I):
- NORTHWESTERN UNIVERSITY
- Udo Rudloff of Bethesda MD (US)
- Serguei Kozlov of Bethesda MD (US)
- Juan Jose Marugan of Gaithersburg MD (US)
- Sui Huang of Chicago IL (US)
- Samarjit Patnaik of Gaithersburg MD (US)
- John C. Braisted of Boyds MD (US)
- Noel T. Southall of Potomac MD (US)
- Marc Ferrer of Potomac MD (US)
- Christopher Dextras of Frederick MD (US)
- John Haslam of Lawrence KS (US)
- Michael Baltezor of Shawnee KS (US)
- A61K31/519
- A61K31/7068
- A61K45/06
- A61K47/12
- A61P35/04
- CPC A61K31/519